statins could reach a large group of diabetic patients, but it needs to be acknowledged that the absolute reduction in events is rather low because of the low baseline risk
statins could reach a largegroup of diabetic patients, but it needs to be acknowledged that the absolute reduction in events is rather low because of the low baseline risk